市場調查報告書
商品編碼
1361116
家庭濫用藥物 (DOA) 測試市場規模 - 按類型(測試杯、測試條)、按樣本類型(唾液、尿液、血液)和 2023 年 - 2032 年全球預測At-home Drug of Abuse (DOA) Testing Market Size - By Type (Test Cups, Test Strips), By Sample Type (Saliva, Urine, Blood) & Global Forecast 2023 - 2032 |
由於人們越來越認知到藥物篩檢在維護公共安全和確保勞動力健康方面發揮的關鍵作用,預計 2023 年至 2032 年家庭藥物濫用 (DOA) 檢測市場規模將達到 7% 的年複合成長率。例如,馬薩諸塞州啟動了許多減少危害的計劃,透過這些計分類發甲苯噻嗪試紙。由於該藥物能夠造成皮膚傷口,過量服用還會導致死亡,因此藥物篩選起著重要作用。
隨著藥物濫用現象的日益普遍,雇主擴大對員工採取藥物檢測政策,而父母和個人也將其用於特定目的。這種意識的提高導致對家用藥物檢測套件的需求更大。
整個家庭濫用藥物檢測市場根據類型、樣本類型和地區進行分類。
預計從 2023 年到 2032 年,測試杯細分市場的年複合成長率將達到 7.3% 左右,因為它們為藥物篩選提供了一種方便用戶使用的一體化解決方案,使流程更加簡單且不易出錯。同時,製造商不斷推出新功能,例如整合溫度條、摻假檢查以及同時測試多種藥物的能力。測試杯反映了人們對可在家中輕鬆執行的具有成本效益且高效的藥物測試解決方案的渴望。
由於人們對非侵入性和無痛檢測方法的日益青睞,預計 2023 年至 2032 年血液樣本領域的年複合成長率將達到 7.3%。傳統的尿液檢測有時會讓人感到不舒服且具侵入性,尤其是在家庭環境中。血液樣本檢測提供了一種侵入性較小、更謹慎且可以提供準確結果的替代方案。隨著技術的不斷進步,血液樣本檢測預計將變得更加方便用戶使用和方便,有利於該細分市場的成長。
由於人們越來越重視健康和安全,尤其是在工作場所和教育機構,亞太地區家庭濫用藥物檢測市場規模預計到 2032 年年複合成長率將達到 8.2%。該地區各國政府和組織正在認知到定期進行藥物篩檢以應對藥物濫用問題的必要性。快速的城市化和可支配收入的增加,使更多人更容易獲得家庭藥物檢測套件,這將積極影響亞太地區的市場動態。
At-home drug of abuse (DOA) testing market size is predicted to record 7% CAGR from 2023 to 2032 due to the increasing awareness and recognition of the critical role that drug screening plays in maintaining public safety and ensuring a healthy workforce. For instance, Massachusetts has launched many harm reduction programs through which test strips for xylazine is being distributed. As the drug has the capability of producing gaping skin wounds and can also cause death in case of overdose, drug screening plays a major role.
With rising prevalence of substance abuse, employers are increasingly adopting drug testing policies for employees, while parents and individuals are also using it for specific purposes. This heightened awareness has led to greater demand for at-home drug testing kits.
The overall at-home drug of abuse testing market is divided based on type, sample type, and region.
The test cups segment is predicted to observe around 7.3% CAGR from 2023 to 2032 as they offer a user-friendly, all-in-one solution for drug screening, making the process more straightforward and less prone to errors. Simultaneously, manufacturers are constantly introducing new features, such as integrated temperature strips, adulteration checks, and the ability to test for multiple drugs simultaneously. Test cups reflects the desire for cost-effective and efficient drug testing solutions that can be easily performed at home.
The blood sample segment is expected to record 7.3% CAGR from 2023 to 2032 due to the growing preference for non-invasive and painless testing methods. Traditional urine-based testing can sometimes be uncomfortable and invasive, especially in at-home settings. Blood sample testing provides an alternative that is less invasive, more discreet, and can offer accurate results. As technology continues to advance, blood sample testing is expected to become even more user-friendly and accessible, favoring the segment growth.
Asia Pacific at-home drug of abuse testing market size is anticipated to witness 8.2% CAGR through 2032 driven by an increased emphasis on health and safety, especially in the workplace and educational institutions. Governments and organizations in the region are recognizing the need for regular drug screening to combat substance abuse issues. The rapid urbanization and increased disposable income, which make at-home drug testing kits more accessible to a wider population, will positively sway the APAC market dynamics.